Evidence map›Paper›PMID 39268490›Full record

ArticleFrontiers in cellular and infection microbiology2024

Synergistic

Xiaoyu Cao, Ni Xiao, Jingyi Huang, Li Li, Lian Zhong, Jun Zhang, Fengyun Wang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Xiaoyu CaoSchool of Traditional Chinese Medicine, Guangdong Pharmaceutical University, Guangzhou, China.
Ni XiaoSchool of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, China.
Jingyi HuangSchool of Traditional Chinese Medicine, Guangdong Pharmaceutical University, Guangzhou, China.
Li LiSchool of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, China.
Lian ZhongSchool of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, China.
Jun ZhangSchool of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, China.
Fengyun WangSchool of Traditional Chinese Medicine, Guangdong Pharmaceutical University, Guangzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: In the face of increasing antifungal resistance among Methods: Using UPLC-Q-TOF/MS Analysis for Identification of Active Compounds in KBN Lotion; FICI for synergy evaluation, XTT and ROS assays for biofilm viability and oxidative stress, fluorescence and confocal laser scanning microscopy (CLSM) for structural and viability analysis, and real-time fluorescence for gene expression. Conclusion: Our study indicates that the combined application of KBN and MN somewhat impacts the structural integrity of

Indexed as

Antifungal AgentsBiofilmsCandida albicansDrug Resistance, FungalDrug SynergismMiconazoleMicrobial Sensitivity TestsFungal ProteinsGene Expression Regulation, FungalHumansMicrobial ViabilityOxidative StressPlant ExtractsReactive Oxygen SpeciesAntifungal AgentsFungal ProteinsMiconazolePlant ExtractsReactive Oxygen SpeciesbiofilmsCandida albicansKBNmiconazole nitratesynergistic

Identifiers

PMID39268490
PMCPMC11390680

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.